MannKind Corp logo

MannKind Corp

FRA:NNFN (USA)   Ordinary Shares
€ 4.51 (+0.09%) Mar 27
At Loss
Market Cap:
€ 1.16B ($ 1.25B)
Enterprise V:
€ 1.14B ($ 1.23B)
Volume:
100.00
Avg Vol (2M):
622.00
Also Trade In:

Business Description

MannKind Corp logo
MannKind Corp
NAICS : 325412 SIC : 2834
ISIN : US56400P7069

Share Class Description:

FRA:NNFN: Ordinary Shares
Description
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Name Current Vs Industry Vs History
Cash-To-Debt 1.08
Equity-to-Asset -0.52
Debt-to-Equity -1.11
Debt-to-EBITDA 13.22
Interest Coverage 0.42
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -7.27
Distress
Grey
Safe
Beneish M-Score -2.55
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 73.72
9-Day RSI 66.92
14-Day RSI 65.01
6-1 Month Momentum % -14.14
12-1 Month Momentum % -13.16

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.59
Quick Ratio 3.31
Cash Ratio 2.83
Days Inventory 145.05
Days Sales Outstanding 37.07
Days Payable 79.55

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.7
Shareholder Yield % 0.41

Financials (Next Earnings Date:2024-05-09 Est.)

FRA:NNFN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

MannKind Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 184.456
EPS (TTM) (€) -0.037
Beta 0.66
Volatility % 50.29
14-Day RSI 65.01
14-Day ATR (€) 0.118649
20-Day SMA (€) 4.255
12-1 Month Momentum % -13.16
52-Week Range (€) 2.97 - 4.962
Shares Outstanding (Mil) 270.42

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

MannKind Corp Filings

Filing Date Document Date Form
No Filing Data

MannKind Corp Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

MannKind Corp Frequently Asked Questions

What is MannKind Corp(FRA:NNFN)'s stock price today?
The current price of FRA:NNFN is €4.51. The 52 week high of FRA:NNFN is €4.96 and 52 week low is €2.97.
When is next earnings date of MannKind Corp(FRA:NNFN)?
The next earnings date of MannKind Corp(FRA:NNFN) is 2024-05-09 Est..
Does MannKind Corp(FRA:NNFN) pay dividends? If so, how much?
MannKind Corp(FRA:NNFN) does not pay dividend.

Press Release

Subject Date
No Press Release